Oxidation of the alarmin IL-33 regulates ST2-dependent inflammation

Nature Communications

Volumn 6, Issue , 2015, Pages

  Cohen, E Suzanne ^a   Scott, Ian C ^a   Majithiya, Jayesh B ^a   Rapley, Laura ^a   Kemp, Benjamin P ^a   England, Elizabeth ^a   Rees, D Gareth ^a   Overed Sayer, Catherine L ^a   Woods, Joanne ^a   Bond, Nicholas J ^a   Veyssier, Christel Séguy ^a   Embrey, Kevin J ^b   Sims, Dorothy A ^c   Snaith, Michael R ^a   Vousden, Katherine A ^a   Strain, Martin D ^a   Chan, Denice T Y ^a   Carmen, Sara ^a   Huntington, Catherine E ^a   Flavell, Liz ^b   Xu, Jianqing ^a   Popovic, Bojana ^a   Brightling, Christopher E ^d,e   Vaughan, Tristan J ^a   Butler, Robin ^a   Lowe, David C ^a   Higazi, Daniel R ^a   Corkill, Dominic J ^a   May, Richard D ^a   Sleeman, Matthew A ^a   Mustelin, Tomas ^c   more..

^a MedImmune Ltd   (United Kingdom)

^b ASTRAZENECA   (United Kingdom)

^c MEDIMMUNE   (United States)

^d UNIVERSITY OF LEICESTER   (United Kingdom)

^e UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE; CYSTINE; CYTOKINE; INTERLEUKIN 1; INTERLEUKIN 13; INTERLEUKIN 18; INTERLEUKIN 1ALPHA; INTERLEUKIN 33; INTERLEUKIN 36; INTERLEUKIN 36BETA; RECEPTOR; ST2 PROTEIN; UNCLASSIFIED DRUG; CELL SURFACE RECEPTOR; IL1RL1 PROTEIN, HUMAN; IL1RL1 PROTEIN, MOUSE; IL33 PROTEIN, HUMAN; IL33 PROTEIN, MOUSE; INTERLEUKIN 1 RECEPTOR LIKE 1 PROTEIN; INTERLEUKIN RECEPTOR;

ASTHMA; BIOACTIVITY; FUNGUS; IMMUNE RESPONSE; MOLECULAR ANALYSIS; OXIDATION; PROTEIN;

ALTERNARIA ALTERNATA; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ASTHMA; BETA SHEET; BINDING SITE; CIRCULAR DICHROISM; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; DISULFIDE BOND; ELECTROPHORETIC MOBILITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG LAVAGE; MALE; MOUSE; NONHUMAN; OXIDATION; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN SECONDARY STRUCTURE; RECEPTOR BINDING; REGULATORY MECHANISM; SIZE EXCLUSION CHROMATOGRAPHY; ANIMAL; BAGG ALBINO MOUSE; GENETICS; IMMUNOLOGY; METABOLISM; OXIDATION REDUCTION REACTION;

ALTERNARIA; MUS;

ANIMALS; ASTHMA; HUMANS; INTERLEUKIN-1 RECEPTOR-LIKE 1 PROTEIN; INTERLEUKIN-33; MALE; MICE; MICE, INBRED BALB C; OXIDATION-REDUCTION; RECEPTORS, CELL SURFACE; RECEPTORS, INTERLEUKIN;

EID: 84941686678     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms9327     Document Type: Article

References (42)

1. Schmitz, J. et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 23, 479-490 (2005).
2. Moussion, C., Ortega, N. & Girard, J. P. The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel alarmin? PLoS ONE 3, e3331 (2008).
3. Pichery, M. et al. Endogenous IL-33 is highly expressed in mouse epithelial barrier tissues, lymphoid organs, brain, embryos, and inflamed tissues: in situ analysis using a novel Il-33-LacZ gene trap reporter strain. J. Immunol. 188, 3488-3495 (2012).
4. Kouzaki, H., Iijima, K., Kobayashi, T., OGrady, S. M. & Kita, H. The danger signal, extracellular ATP, is a sensor for an airborne allergen and triggers IL-33 release and innate Th2-type responses. J. Immunol. 186, 4375-4387 (2011).
5. Kakkar, R., Hei, H., Dobner, S. & Lee, R. T. Interleukin 33 as a mechanically responsive cytokine secreted by living cells. J. Biol. Chem. 287, 6941-6948 (2012).
6. Haenuki, Y. et al. A critical role of IL-33 in experimental allergic rhinitis. J. Allergy Clin. Immunol. 130, 184-94.e11 (2012).
7. Ali, S. et al. IL-1 receptor accessory protein is essential for IL-33-induced activation of T lymphocytes and mast cells. Proc. Natl Acad. Sci. USA 104, 18660-18665 (2007).
8. Chackerian, A. A. et al. IL-1 receptor accessory protein and ST2 comprise the IL-33 receptor complex. J. Immunol. 179, 2551-2555 (2007).
9. Grotenboer, N. S., Ketelaar, M. E., Koppelman, G. H. & Nawijn, M. C. Decoding asthma: translating genetic variation in IL33 and IL1RL1 into disease pathophysiology. J. Allergy Clin. Immunol 131, 856-865 (2013).
10. Prefontaine, D. et al. Increased expression of IL-33 in severe asthma: evidence of expression by airway smooth muscle cells. J. Immunol. 183, 5094-5103 (2009).
11. Prefontaine, D. et al. Increased IL-33 expression by epithelial cells in bronchial asthma. J. Allergy Clin. Immunol. 125, 752-754 (2010).
12. Saglani, S. et al. IL-33 promotes airway remodeling in pediatric patients with severe steroid-resistant asthma. J. Allergy Clin. Immunol. 132, 676-685.e13 (2013).
13. Kaur, D. et al. IL-33 drives airway hyper-responsiveness through IL-13- mediated mast cell: airway smooth muscle crosstalk. Allergy 70, 556-567 (2015).
14. Jackson, D. J. et al. IL-33-dependent type 2 inflammation during rhinovirusinduced asthma exacerbations in vivo. Am. J. Respir. Crit. Care Med. 190, 1373-1382 (2014).
15. Lefrancais, E. et al. IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G. Proc. Natl Acad. Sci. USA. 109, 1673-1678 (2012).
16. Luthi, A. U. et al. Suppression of interleukin-33 bioactivity through proteolysis by apoptotic caspases. Immunity 31, 84-98 (2009).
17. Cayrol, C. & Girard, J. P. The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1. Proc. Natl Acad. Sci. USA 106, 9021-9026 (2009).
18. Palmer, G. et al. The IL-1 receptor accessory protein (AcP) is required for IL-33 signaling and soluble AcP enhances the ability of soluble ST2 to inhibit IL-33. Cytokine 42, 358-364 (2008).
19. Zhao, J. et al. F-box protein FBXL19-mediated ubiquitination and degradation of the receptor for IL-33 limits pulmonary inflammation. Nat. Immunol. 13, 651-658 (2012).
20. Zhao, J. et al. Focal adhesion kinase-mediated activation of glycogen synthase kinase 3b regulates IL-33 receptor internalization and IL-33 signaling. J. Immunol. 194, 795-802 (2015).
21. Snelgrove, R. et al. Alternaria-derived serine protease activity drives IL-33-mediated asthma exacerbations. J Allergy Clin Immunol. 134, 583-592 (2014).
22. Lingel, A. et al. Structure of IL-33 and its interaction with the ST2 and IL-1RAcP receptors-insight into heterotrimeric IL-1 signaling complexes. Structure 17, 1398-1410 (2009).
23. Liu, X. et al. Structural insights into the interaction of IL-33 with its receptors. Proc. Natl Acad. Sci. USA 110, 14918-14923 (2013).
24. Chang, B. S. et al. Formation of an active dimer during storage of interleukin-1 receptor antagonist in aqueous solution. Biophys. J. 71, 3399-3406 (1996).
25. Craig, S. et al. Conformation, Stability and folding of Interleukin1b. Biochemistry 26, 3570-3576 (1987).
26. Hailey, K. L. et al. Pro-interleukin (IL)-1b shares a core region of stability as compared with mature IL-1b while maintaining a distinctly different configurational landscape. J. Biol. Chem. 284, 26137-26148 (2009).
27. Hazudat, D. et al. Purification and characterisation of Human Recombinant Precursor Interleukin 1b. J. Biol. Chem. 264, 1689-1693 (1989).
28. Meyers, C. A. et al. Purification and characterization of Human recombinant interleukin-1b. J. Biol. Chem. 262, 11176-11181 (1987).
29. Brigham, M. P. et al. The concentrations of cysteine and cystine in human blood plasma. J Clin Invest. 39, 1633-1638 (1960).
30. Matsuyama, Y. et al. Increased levels of interleukin 33 in sera and synovial fluid from patients with active rheumatoid arthritis. J. Rheumatol. 37, 18-25 (2010).
31. Yanaba, K. et al. Serum IL-33 levels are raised in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosis. Clin. Rheumatol. 30, 825-830 (2011).
32. Kearley, J. et al. Cigarette smoke silences innate lymphoid cell function in the lung, facilitating an interleukin-33-dependent, exacerbated type I response to infection. Immunity 42, 566-579 (2015).
33. Garlanda, C., Dinarello, C. A. & Mantovani, A. The interleukin-1 family: back to the future. Immunity 39, 1003-1018 (2013).
34. Ozen, S. & Bilginer, Y. A clinical guide to autoinflammatory diseases: familial Mediterranean fever and next-of-kin. Nat. Rev. Rheumatol. 10, 135-417 (2014).
35. Yamamoto, Y. et al. Generation of highly stable IL-18 based on a ligandreceptor complex structure. Biochem. Biophys. Res. Commun. 317, 181-186 (2004).
36. Economides, A. N. et al. Cytokine traps: multi-component, high-affinity blockers of cytokine action. Nat. Med. 9, 47-52 (2003).
37. Schanda, P. et al. Very fast two-dimensional NMR spectroscopy for real-time investigation of dynamic events in proteins on the time scale of seconds. J. Am. Chem. Soc. 127, 8014-8015 (2005).
38. Kelly, S. M. et al. How to study proteins by Circular Dichroism. Biochim. Biophys. Acta. 1751, 119-139 2005.
39. Houde, D. et al. Post-translational modifications differentially affect IgG1 conformation and receptor binding. Mol. Cell Proteomics 9, 1716-1728 (2010).
40. Andersen, H. B. et al. Comparison of short term in vitro cultured human mast cells from different progenitors-peripheral blood-derived progenitors generate highly mature and functional mast cells. J. Immunol. Methods 336, 166-174 (2008).
41. From the Global Strategy for Asthma Management and Prevention, Global Initiative for Asthma (GINA) 2010. Available at: http://www.ginasthma.org/ (accessed on 01 July 2009).
42. Prince, S. et al. GROMACS 4.5: a high-throughput and highly parallel open source molecular simulation toolkit. Bioinformatics 29, 845-854 (2013).